* First completed diamond hole BYLDD019 intersected 127m of strongly mineralised pegmatite from 609m (with a true width of ~60m), with assays pending (The Company will update the market when laboratory analytical
results become available, which is currently expected to be early October 2023 in respect of BYDD019).
Looks promising (of BYDD019 due to surrounding assayed holes with good/great results). Im in. Also LPM has a relatively simple/tight register with total SOI of circa 115m plus 10.5m in options (6m with ex price 25c in Oct 2026 and 4m with ex price 31.25c in April 2025). LPM still had circa $8.3m in the bank by the end of June 2023 (June qtrly total spend was around $1m). Looks very positive (in grand scheme e.g. Li macro, location, proximity to facilities etc..), and would be ideal if their admin/staff cost can be tightened a bit (as a junior explorer)..
- Forums
- ASX - By Stock
- LPM
- [INTERVIEW] From the Floor with Lithium Plus Minerals Non-Executive Director - Simon Kidston
[INTERVIEW] From the Floor with Lithium Plus Minerals Non-Executive Director - Simon Kidston, page-10
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LPM (ASX) to my watchlist
(20min delay)
|
|||||
Last
14.5¢ |
Change
0.005(3.57%) |
Mkt cap ! $19.18M |
Open | High | Low | Value | Volume |
14.5¢ | 14.5¢ | 14.5¢ | $2.791K | 19.25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 9250 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 26114 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 9250 | 0.145 |
2 | 25585 | 0.140 |
2 | 11202 | 0.135 |
1 | 50000 | 0.130 |
1 | 15000 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 26114 | 3 |
0.160 | 5702 | 2 |
0.165 | 7601 | 2 |
0.175 | 35000 | 1 |
0.180 | 87080 | 2 |
Last trade - 15.42pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
LPM (ASX) Chart |